STERIS plc (NYSE:STE) Stock Position Reduced by Diversified Trust Co

Diversified Trust Co decreased its stake in STERIS plc (NYSE:STE) by 7.6% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,924 shares of the medical equipment provider’s stock after selling 406 shares during the quarter. Diversified Trust Co’s holdings in STERIS were worth $1,107,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the stock. First Hawaiian Bank raised its position in shares of STERIS by 0.4% during the first quarter. First Hawaiian Bank now owns 13,857 shares of the medical equipment provider’s stock valued at $3,115,000 after buying an additional 50 shares during the last quarter. Park Edge Advisors LLC increased its position in shares of STERIS by 1.2% during the fourth quarter. Park Edge Advisors LLC now owns 4,409 shares of the medical equipment provider’s stock valued at $969,000 after purchasing an additional 51 shares during the period. UMB Bank n.a. raised its stake in shares of STERIS by 7.8% in the fourth quarter. UMB Bank n.a. now owns 716 shares of the medical equipment provider’s stock valued at $157,000 after purchasing an additional 52 shares in the last quarter. Kentucky Retirement Systems Insurance Trust Fund lifted its position in STERIS by 1.5% in the fourth quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 3,520 shares of the medical equipment provider’s stock worth $774,000 after purchasing an additional 53 shares during the period. Finally, Legacy Wealth Asset Management LLC boosted its stake in STERIS by 1.5% during the fourth quarter. Legacy Wealth Asset Management LLC now owns 3,544 shares of the medical equipment provider’s stock worth $779,000 after buying an additional 54 shares in the last quarter. Institutional investors and hedge funds own 94.69% of the company’s stock.

Insider Activity

In other STERIS news, VP Renato Tamaro sold 1,154 shares of the company’s stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $231.64, for a total transaction of $267,312.56. Following the transaction, the vice president now owns 6,677 shares of the company’s stock, valued at approximately $1,546,660.28. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other STERIS news, Director Jacqueline B. Kosecoff sold 4,584 shares of the business’s stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $231.53, for a total transaction of $1,061,333.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, VP Renato Tamaro sold 1,154 shares of the company’s stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $231.64, for a total transaction of $267,312.56. Following the transaction, the vice president now owns 6,677 shares in the company, valued at $1,546,660.28. The disclosure for this sale can be found here. Insiders have sold 7,762 shares of company stock valued at $1,798,477 over the last three months. 1.14% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on STE shares. JMP Securities reaffirmed a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a report on Thursday, May 9th. Piper Sandler reaffirmed a “neutral” rating and set a $225.00 price objective (up from $220.00) on shares of STERIS in a report on Friday, May 10th. Needham & Company LLC reissued a “hold” rating on shares of STERIS in a report on Friday, May 10th. Finally, StockNews.com upgraded STERIS from a “hold” rating to a “buy” rating in a research report on Saturday, June 15th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, STERIS has a consensus rating of “Moderate Buy” and an average price target of $241.60.

STERIS Stock Performance

NYSE:STE opened at $218.54 on Tuesday. The stock has a market capitalization of $21.60 billion, a P/E ratio of 57.21 and a beta of 0.83. STERIS plc has a 1 year low of $195.47 and a 1 year high of $254.00. The firm has a 50 day moving average of $220.44 and a 200-day moving average of $221.24. The company has a current ratio of 3.08, a quick ratio of 2.36 and a debt-to-equity ratio of 0.49.

STERIS (NYSE:STE) last posted its quarterly earnings data on Wednesday, May 8th. The medical equipment provider reported $2.58 EPS for the quarter, topping analysts’ consensus estimates of $2.41 by $0.17. STERIS had a return on equity of 13.73% and a net margin of 6.95%. The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.41 billion. During the same quarter in the previous year, the firm earned $2.30 earnings per share. The business’s revenue was up 10.8% on a year-over-year basis. As a group, sell-side analysts anticipate that STERIS plc will post 9.24 EPS for the current fiscal year.

STERIS Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, June 26th. Stockholders of record on Wednesday, June 12th were given a dividend of $0.52 per share. The ex-dividend date of this dividend was Wednesday, June 12th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 0.95%. STERIS’s payout ratio is 54.45%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.